The following is a summary of “Physicians’ experiences of assessing and supporting fatigued patients in primary care: a focus ...

A new explanation for why some people are in long-term pain says it could be caused by the immune system attacking the person ...

Shan critiqued several factors of the study, including use of Patient Global Impression of Change (PGIC) for the primary endpoint, the statistical analysis, the control group selection, and ...

Macadamia nuts have a rich nutritional profile. They are packed with healthy fats, which serve as a steady and long-lasting ...

The Pain Management Unit at Quirónsalud Torrevieja Hospital highlights the need to improve healthcare for patients living ...

FDA concluded that AXS-14’s New Drug Application was not sufficiently complete for substantive review, citing concerns with one of two clinical trials in fibromyalgia patients.

The FDA rejected Axsome's AXS-14 fibromyalgia, prompting a new trial and pushing the expected drug launch to 2028.

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

An online positive affect program improved mood, reduced pain and fatigue, and boosted response to daily positives in adults ...

You're sleeping well, cutting down on screen time at night... and yet, fatigue persists. If exhaustion has become your daily ...